Koers Proto Script Pharmaceutical Corp. Other OTC
Aandelen
PSCR
US74373V1052
Bedrijfsondersteunende diensten
Omzet 2015 | 881K 814K | Omzet 2016 | 789K 729K | Marktkapitalisatie | 311 mln. 287 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2015 | - 0 | Nettowinst (verlies) 2016 | -7 mln. -6,47 mln. | EV/omzet 2015 * | - |
Nettoschuld 2015 | 27,07K 25,01K | Nettoschuld 2016 | 47,78K 44,14K | EV/omzet 2016 | 394 x |
K/w-verhouding 2015 * |
-
| K/w-verhouding 2016 |
-41,4
x | Werknemers | - |
Dividendrendement 2015 * |
-
| Dividendrendement 2016 |
-
| Vrij verhandelbaar | 89,82% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michelle Rico
CEO | Chief Executive Officer | 56 | 29-06-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michelle Rico
CEO | Chief Executive Officer | 56 | 29-06-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,10% | 72,21 mld. | |
+5,35% | 17,12 mld. | |
+15,11% | 14,08 mld. | |
+14,91% | 12,91 mld. | |
+11,73% | 9,8 mld. | |
-14,43% | 7,29 mld. | |
-10,54% | 5,59 mld. | |
+1,74% | 5,19 mld. | |
+2,17% | 5,12 mld. |